Did You Know?

Editor’s Picks

Latest News

Sibel Health Secures Additional Series C Extension Funding to $39 million from Key Strategic Investors and Announces New Board of Director Appointments

CHICAGO, Oct. 14, 2025 /PRNewswire/ -- Sibel Health, an award-winning digital health company, today announced the close of a Series...

Medical Care Technologies Inc. (OTC PINK:MDCE) Accelerates Growth Trajectory as Its Diverse AI Ecosystem Eyes $450 Billion in Multi-Market Potential

MESA, ARIZONA / ACCESS Newswire / October 14, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announced that its...

Red Light Holland Secures Second United States Controlled Substances Import Permit for the Company’s Psilocybin Through FDA-Compliant, DEA-Registered Partner Irvine Labs

Red Light Holland granted Second DEA Import Permit through Irvine Labs for expanded psilocybin research programThis United States Controlled Substances...

Celularity Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Results Demonstrating the Safety and Efficacy of Human Placenta-Derived Cells (PDA-002) for Diabetic Foot Ulcers Complicated by Peripheral Artery Disease

First-in-class regenerative therapy for diabetic foot ulcers complicated by peripheral artery diseaseCelularity PDA-002 achieved durable wound healing with just two...

error: Content is protected !!